Approval · Notice of Compliance 6292 · 2005
BONEFOS: Notice of Compliance 6292
Issued February 22, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6292
- Date
- February 22, 2005
- Company
- Berlex Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Bone metabolism regulator (anti-hypercalcemic agent)
Products in this notice
Medicinal ingredients
- CLODRONATE DISODIUM TETRAHYDRATE 400 MG per CAP
- CLODRONATE DISODIUM TETRAHYDRATE 60 MG per ML